Tue, Oct 08 · 7:30

We will welcome over 200 attendees representing global pharmaceutical companies, leading biotech companies and internationally renowned academic institutions to discuss 40+ presentations and case studies on the key issues in translational science, personalised medicine and clinical development.

4 Interactive Streams:

- The Role of Biomarkers in Translational Science
- Biomarkers in Clinical Development and Clinical Trials
- Biomarkers for Precision Medicine and Targeted Therapies
- Genomic Biomarkers in Clinical Development and Clinical Trials

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Co-located with the 2nd Annual Advances in Immuno-Oncology USA Congress

Website: https://go.evvnt.com/385819-3?pid=5731

Price:
Registration Available from : USD 445.0

Speakers: Stefan Scherer, Senior Vice President, Clinical Development, Cellectis, Alessandra Di Bacco, Senior Director, Translational Medicine, Takeda, Lars Bukhave Rasmussen, Vice President, Head of Marketing (Patient Solitions), LEO Pharma Inc., John Allinson, Vice President, BDS, Nuzhat Pathan, Director, Translational Oncology, Pfizer, Daniela Ennulat, Director of Pathology and Senior Science Fellow In Vitro In Vivo Translation, GlaxoSmithKline, Katherine Call, Senior Director and Head, Proteogenomics Translational Sciences, Sanofi